Executive Director:

Steven L. Spitalnik, MD is Professor and Executive Vice-Chair of the Department of Pathology & Cell Biology at Columbia University. In addition to serving as the Medical Director of the Clinical Laboratories at Columbia University Irving Medical Center-New York Presbyterian Hospital, he is an attending physician in Transfusion Medicine and is Co-Director of the Laboratory of Transfusion Biology, which pursues basic and translational research in red blood cell biology.

Deputy Director:

Brie A. Stotler, MD, MPH is Assistant Professor of Pathology & Cell Biology at Columbia University. In addition to serving as the Medical Director of the Clinical Laboratories at the Allen Hospital-New York Presbyterian Hospital, she is an attending physician in Transfusion Medicine at the Columbia University Irving Medical Center-New York Presbyterian Hospital. She pursues translational and clinical research in transfusion medicine and has an interest in global health

Members of the Board of Directors:

Gian Carlo Di Renzo, MD, PhD is Professor and Chair of the Department of Obstetrics and Gynecology at the University of Perugia in Italy. He is Director of both the Reproductive and Perinatal Medicine Center in Perugia and founder of the Permanent International and European School of Perinatal and Reproductive Medicine (PREIS) in Florence. He is also Director of the Department of Education & Communication at FIGO after being General Secretary (2012-2018).

Members of the Board of Directors:

Isaac Odame, MB ChB, MRCP (UK), FRCPath, FRCPC is the Professor and Alexandra Yeo Chair in Haematology in the Departments of Medicine and Paediatrics, and the Director, Division of Haematology, all at the University of Toronto, in Toronto, Canada. In addition, he is the Head of the Haematology Section in the Division of Haematology/Oncology at The Hospital for Sick Children in Toronto. He is also the Medical Director of The Global Sickle Cell Disease Network, Centre for Global Child Health.

Members of the Board of Directors:

Hua Shan, MD, PhD is a Professor and Medical Director of the Transfusion Medicine Service at Stanford University Medical Center. She has led multiple, large education and research programs on blood safety and clinical transfusion practice, particularly focusing on improving the practice of transfusion medicine in China.

Members of the Board of Directors:

Ellen van der Schoot, MD, PhD is Professor of Experimental Immunohematology at the University of Amsterdam, and Head of the Department of Immunohematology at Sanquin Research, Amsterdam, the Netherlands. Her research focuses on alloimmunization against blood group antigens, with the aim of developing new preventive, diagnostic, and therapeutic approaches towards hemolytic transfusion reactions and Hemolytic Disease of the Fetus and Newborn. She has published more than 300 peer-reviewed articles.

Members of the Board of Directors:

Gerard H.A. Visser, MD, PhD is Emeritus Professor of Obstetrics, University Medical Center, Utrecht, the Netherlands. He is the past President of the European Association of Perinatal Medicine and a member and immediate past Chair of FIGO’s Committee on Safe Motherhood and Newborn Health. From the latter position he became one of the initiators of their Rh eradication program.